Infrea

Infrea

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

Infrea - Road tripping with Netel

09 juli 2026

  • The merger in focus for now
  • Three announced orders in the quarter
  • Infrea's share price pegged to Netel's

Merger with Netel

The main event in the quarter is the merger between Infrea and Netel, as we wrote about in our Fast Comment (Infrea and Netel to merger). Completion is conditional on approval at extraordinary general meetings in August '26, competition clearance, and Netel's rights issue of ~SEK 127m, with registration at the Swedish Companies Registration Office expected in Q4'26. A prospectus with more detail on the combined company will be published in July '26. The combined entity will have revenues of ~SEK 5bn and is expected to generate annual cost synergies of ~SEK 50m within 12–24 months, with Infrea's CEO Martin Reinholdsson as new CEO. The merger diversifies the portfolio, lowers the risk, and lets the company leverage its greater scale. Infrea's management has a proven track record of turning around infrastructure companies, from Infrea in '23, key for Netel given its current state.

Focus in the quarter

During the quarter, Infrea has announced three order wins, one of which contains several contracts, for an amount of SEK 360m. It is positive to see Infrea being able to take on larger contracts, leveraging the scale of the group. For estimates, we lower '26e sales by 1% and '26e EBITA by SEK 3m as we believe Q2'26 will have a tough comp in Paving Services. We now forecast '26 adj. EBITA of SEK 53m (SEK 49m '25), accelerating to SEK 65m in 2027e, as margins rise from 2.2% in '25 to 3.0% in '27e.

Infrea is pegged to Netel

For now, Infrea's share price is pegged to Netel's, and we have therefore removed our fair value range. The merger's exchange ratio is 17 new Netel shares for every 4 Infrea shares, i.e., 4.25 Netel shares per Infrea share. Netel closed today at SEK 3.31 per share, implying a value of SEK 14.07 per Infrea share. Netel reports on 10 July and currently has no analyst consensus.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-15 Infrea - Strong quarter but pegged to Netel Infrea Analys
2026-07-15 Coor - Solid earnings despite softer sales Coor Analys
2026-07-15 Svedbergs Group - Nordics and one-offs weigh Svedbergs G.. Analys
2026-07-14 Nexam Chemical - Solid Q2, profitability within r... Nexam Chemical Analys
2026-07-14 Nexam Chemical - Record sales and first positive ... Nexam Chemical Analys
2026-07-14 Eastnine - Warsaw to become the largest market Eastnine Analys
2026-07-13 Ascelia Pharma - CRL update Ascelia Pharma Analys
2026-07-13 Medicover - Steady as she goes Medicover Analys
2026-07-13 Arctic Paper - Pulp beats paper Arctic Paper Analys
2026-07-13 Studsvik - Gearing up for the new-build era Studsvik Analys
2026-07-10 StrongPoint - The American dream StrongPoint Analys
2026-07-10 Careium - The pressure valve starting to open Careium Analys
2026-07-10 StrongPoint - Solid Q2 performance StrongPoint Analys
2026-07-10 Careium - Growth's comeback tour continues Careium Analys
2026-07-09 Infrea - Road tripping with Netel Infrea Analys
2026-07-08 Alligo - Softer growth, but margin recovery conti... Alligo Analys
2026-07-08 Qliro - Key earnings drivers intact Qliro Analys
2026-07-07 Nexam Chemical - We expect a firmer sequential qu... Nexam Chemical Analys
2026-07-07 Eastnine - Adding in Warsaw Eastnine Analys
2026-07-06 Ovzon - No Q2 fireworks, but plenty of fuel Ovzon Analys